Parkinson’s disease is a challenging condition that affects millions of people around the world. It is known for causing ...

Subtle clues—from handwriting to snoring—can reveal the earliest warnings of illness. Here's how to read your own distress ...

People with Parkinson’s disease are to benefit from cutting edge AI technology that allows neuroscientists to safely test medication and treatment on a ‘digital twin’ brain, thanks to a £1m funding ...

Why digital measurements startup Koneksa Health thinks it can help pharma measure if their drugs are effective in people with ...

The new Ochsner site will contribute to uncovering additional genes as well as examine health disparities and care access for ...

Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...

Data from a late-stage study shows that treatment with flexible doses of ABBV's tavapadon reduced the burden of Parkinson's ...

Boston-based CervoMed (CRVO) said the Phase 2b trial of its neflamapimod did not meet significant statistical thresholds for its primary endpoint of a change in the Clinical Dementia Rating Sum of ...

Parkinson’s disease is a progressive neurological disorder in which ongoing changes in the brain affect and interfere with ...

“The positive results across all three Phase 3 TEMPO trials underscore the potential of tavapadon as a first-in-class D1/D5 ...

Commonly prescribed drugs could increase risk of dementia, scientists have warned. Research conducted by the University of ...